List view / Grid view
20 July 2015 | By Victoria White
Certain patients with type 2 diabetes may have specific genetic risk factors that put them at higher risk for developing Alzheimer’s disease...
20 July 2015 | By Victoria White
Lower levels of cholesterol in certain immune cells may help explain why some HIV-infected people are able to naturally control disease progression...
20 July 2015 | By Victoria White
Cellecta has announced the receipt of Phase I SBIR grant funds from the NIH to further its CRISPR-mediated genome-editing library...
17 July 2015 | By Oxford Global
In the run up to our 2015 Next Generation Sequencing Congress, Single Cell Congress & Genome Editing Congress we spoke with Jacqueline Boultwood, University of Oxford...
17 July 2015 | By Biosimilars and Biobetters
This year's conference will address recent regulatory updates, pharmacovigilance of biosimilars, patent litigation, market access & global market developments...
17 July 2015 | By Victoria White
Scientists have found that existing anti-malaria drugs, Chloroquine and Amodiaquine, could be a potential treatment for Parkinson's disease...
16 July 2015 | By Victoria White
Novogen has received notification FDA that its chemotherapy candidate drug, Anisina, has been granted Orphan Drug Designation for neuroblastoma...
16 July 2015 | By Victoria White
Achaogen has been awarded a $4.5 million contract for the discovery and development of LpxC inhibitors for the treatment of bacterial infections...
16 July 2015 | By Victoria White
Researchers have discovered two chemical compounds that effectively stop the growth of brain cancer cells and breast tumours by inhibiting the Stat3 protein...
16 July 2015 | By Victoria White
Researchers have developed a user-friendly resource to accompany the powerful CRISPR/Cas9 tool, which has been widely adopted to make precise changes in DNA...
15 July 2015 | By Victoria White
Galapagos has entered into a licensing agreement with the HUB foundation for use of Organoid Technology for preclinical research in cystic fibrosis and IBD...
15 July 2015 | By Victoria White
MUSC and Bristol-Myers Squibb have entered into a research collaboration focused on fibrotic diseases, including scleroderma and renal fibrosis...
15 July 2015 | By Victoria White
Scientists have shown that gene therapy can give protection to the light-sensitive photoreceptor cells responsible for colour vision in retinitis pigmentosa...
15 July 2015 | By Victoria White
GSK and MRC are to collaborate on a unique open innovation research initiative aiming to improve scientists’ understanding of inflammatory diseases...
15 July 2015 | By Victoria White
Weizmann Institute scientists have shown how it might be possible to use embryonic stem cells to repair damaged lung tissue...
